The Joplin Globe
Flightpath Biosciences Begins Human Clinical Testing of the World’s First Narrow-Spectrum Antibiotic Targeting Lyme Disease
This announcement coincides with Lyme Awareness Month and is meant to provide the community-at-large with a long-awaited reason for optimism related to new treatment strategies. Lyme disease ...
5 days ago